Somavert Market Report Spreads In 84 Pages with 128 Tables and Figures
Somavert Market 2023 : Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Somavert is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Somavert is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Somavert is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Somavert include Pfizer. etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Top Key Players:
- Pfizer
Somavert Market By Applications
- Hospital
- Pharmacy
Somavert Market By Types
- Prefilled
- Non-prefilled
Get a Sample PDF of report –https://www.360researchreports.com/enquiry/request-sample/21760278
Triflic Acid Market to Exhibit a Remarkable CAGR
The Hydrotalcite Market is expected to grow at significant CAGR
The Glue Remover Market is expected to grow at significant CAGR
The Ceteareth-30 Market is expected to grow at significant CAGR